Clinical Research

Government-funded program wants better AI for managing heart failure in the US
The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists.
Acoramidis bests tafamidis in head-to-head comparison of ATTR-CM drugs
Acoramidis was associated with a 43% lower risk of diuretic intensification and a 34% lower risk of clinical worsening overall.
TAVR timing: Waiting more than 6 months may hurt survival odds
When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.
European Society of Cardiology joins effort to improve access to heart data
Accessing cardiology data for research or population health initiatives is still quite difficult in Europe. Could this new project help reverse that trend?
5 practice-changing trials from ESC Congress 2026
Damodhar Suresh, MD, spoke to Cardiovascular Business about some of the biggest studies presented during the annual ESC conference in Munich, Germany.

Statin therapy benefits high-risk patients with no prior history of CVD

Two separate studies examined the controversial topic of prescribing statins to high-risk elderly patients who do not already have high cholesterol or cardiovascular disease.

doctor fruits vegetables vegetarian diet

Plant-based vs. meat-based diets: Going vegan linked to better cardiovascular health in identical twin study

Researchers focused on 22 pairs of identical twins for 8 weeks, asking one twin to follow a healthy vegan diet and the other to follow a healthy omnivorous diet.

Interruptions during mammogram reading increase inaccuracies, radiologist burnout

Interruptions while reading breast images contribute to emotions associated with physician burnout, according to a new study.

Cleveland Clinic's cardiology department is consistently ranked one of the top cardiac centers in the country by U.S. News and World Report.

Cleveland Clinic and Canon establish state-of-the-art research center

The collaboration is part of the Cleveland Innovation District, a more than $500 million public-private partnership for advancing medical research.

Avidity Biosciences inks drug discovery deal worth up to $2.3B with industry heavyweight

Avidity Biosciences, a San Diego-based biopharmaceutical company, is expanding its ongoing collaboration with Bristol Myers Squibb to identify new cardiovascular therapies.